Send us Feedback

Eli Lilly and Company (LLY)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

LLY » Topics » Securities Authorized for Issuance Under Equity Compensation Plans

This excerpt taken from the LLY 10-K filed Feb 22, 2010.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table presents information as of December 31, 2009, about our compensation plans under which shares of Lilly stock have been authorized for issuance.
 
                         
                (c) Number of
 		 
                securities
 		 
    (a) Number of
 		          remaining available
 		 
    securities to be
 		          for future issuance
 		 
    issued upon
 		    (b) Weighted-average
 		    under equity
 		 
    exercise of
 		    exercise price of
 		    compensation plans
 		 
    outstanding
 		    outstanding
 		    (excluding
 		 
    options, warrants,
 		    options, warrants,
 		    securities
 		 
Plan Category   and rights     and rights     reflected in (a))  
   
 
Equity compensation plans approved by security holders
    52,854,572     $ 68.52       84,578,959  
Equity compensation plans not approved by security holders1
    6,594,445       76.11       02  
     
     
Total
    59,449,017     $ 69.36       84,578,959  
 
1 Represents shares in the Lilly GlobalShares Stock Plan, which permitted the company to grant stock options to non-management employees worldwide. The plan was administered by the senior vice president responsible for human resources. The stock options are nonqualified for U.S. tax purposes. The option price cannot be less than the fair market value at the time of grant. The options shall not exceed 11 years in duration and shall be subject to vesting schedules established by the plan administrator. There are provisions for early vesting and early termination of the options in the event of retirement, disability, and death. In the event of stock splits or other recapitalizations, the administrator may adjust the number of shares available for grant, the number of shares subject to outstanding grants, and the exercise price of outstanding grants.
2 The Lilly GlobalShares Stock Plan was terminated in February 2009. No more grants can be made under this plan.
 
 
80

 

 
Item 13.   Certain Relationships and Related Transactions, and Director Independence
 
These excerpts taken from the LLY 10-K filed Feb 27, 2009.
Securities Authorized for Issuance Under Equity Compensation Plans
 
Information on securities authorized for issuance under our equity compensation plans can be found in the Proxy Statement under “Item 4 − Reapproval of Material Terms of Performance Goals for the Eli Lilly and Company Bonus Plan” at page 116. That information is incorporated in this report by reference.


-90-

 

Item 13.     Certain Relationships and Related Transactions, and Director Independence
 
Securities
Authorized for Issuance Under Equity Compensation
Plans


 



Information on securities authorized for issuance under our
equity compensation plans can be found in the Proxy Statement
under “Item 4 − Reapproval of Material
Terms of Performance Goals for the Eli Lilly and Company Bonus
Plan” at page 116. That information is incorporated in
this report by reference.





-90-




 


















Item 13.    
Certain
Relationships and Related Transactions, and Director Independence



 




These excerpts taken from the LLY 10-K filed Oct 21, 2008.
Securities Authorized for Issuance Under Equity Compensation Plans
 
Information on securities authorized for issuance under our equity compensation plans can be found in the Proxy Statement under “Item 5 – Amendment of the 2002 Lilly Stock Plan” at page 108.


-84-

Table of Contents

 
Item 13.     Certain Relationships and Related Transactions, and Director Independence
 
Securities
Authorized for Issuance Under Equity Compensation
Plans


 



Information on securities authorized for issuance under our
equity compensation plans can be found in the Proxy Statement
under “Item 5 – Amendment of the 2002 Lilly
Stock Plan” at page 108.





-84-




Table of Contents










 















Item 13.    
Certain
Relationships and Related Transactions, and Director Independence



 




These excerpts taken from the LLY 10-K filed Feb 29, 2008.
Securities Authorized for Issuance Under Equity Compensation Plans
 
Information on securities authorized for issuance under our equity compensation plans can be found in the Proxy Statement under “Item 5 – Amendment of the 2002 Lilly Stock Plan” at page 108.


-82-

 

Item 13.     Certain Relationships and Related Transactions, and Director Independence
 
Securities
Authorized for Issuance Under Equity Compensation
Plans


 



Information on securities authorized for issuance under our
equity compensation plans can be found in the Proxy Statement
under “Item 5 – Amendment of the 2002 Lilly
Stock Plan” at page 108.





-82-




 


















Item 13.    
Certain
Relationships and Related Transactions, and Director Independence



 




This excerpt taken from the LLY 10-K filed Feb 28, 2007.
Securities Authorized for Issuance Under Equity Compensation Plans
 
The following table presents information as of December 31, 2006, regarding our compensation plans under which shares of Lilly common stock have been authorized for issuance.
 
                         
    (a) Number of
     (b) Weighted-
     (c) Number of
  
    securities to be
     average exercise
     securities remaining
  
    issued
     price of
     available for future
  
    upon exercise of
     outstanding
     issuance under equity
  
    outstanding
     options,
     compensation plans
  
    options,
     warrants,
     (excluding securities
  
Plan category   warrants, and rights     and rights     reflected in column (a))  
 
Equity compensation plans approved by security holders
    79,012,219       $68.59       45,157,699  
Equity compensation plan not approved by security holders(1)
    9,797,960       75.74       320,555  
                         
Total
    88,810,179       69.38       45,478,254  
                         
 
(1)     Represents shares in the Lilly GlobalShares Stock Plan, which permits the company to grant stock options to nonmanagement employees worldwide. The plan is administered by the senior vice president responsible for human resources. The stock options are nonqualified for U.S. tax purposes. The option price cannot be less than the fair market value at the time of grant. The options shall not exceed 11 years in duration and shall be subject to vesting schedules established by the plan administrator. There are provisions for early vesting and early termination of the options in the event of retirement, disability, and death. In the event of stock splits or other recapitalizations, the administrator may adjust the number of shares available for grant, the number of shares subject to outstanding grants, and the exercise price of outstanding grants.
 
Item 13.     Certain Relationships and Related Transactions, and Director Independence
 

EXCERPTS ON THIS PAGE:

10-K
Feb 22, 2010
10-K (2 sections)
Feb 27, 2009
10-K (2 sections)
Oct 21, 2008
10-K (2 sections)
Feb 29, 2008
10-K
Feb 28, 2007

RELATED TOPICS for LLY:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki